Ergometrine Other names: Ergonovine maleate

Chemical formula: C₁₉H₂₃N₃O₂  Molecular mass: 325.405 g/mol  PubChem compound: 443884

Therapeutic indications

Ergometrine is indicated for:

Active management of the third stage of labour

Population group: women, only adults (18 - 65 years old)

Ergometrine is used in the active management of the third stage of labour.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Post-partum haemorrhage

Population group: women, only adults (18 - 65 years old)

Ergometrine is used in the treatment of post-partum haemorrhage.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Ergometrine is contraindicated in the following cases:

Hypersensitivity to ergometrine

Ergometrine allergy

Pregnancy

Pregnancy

Sepsis

Systemic infection

Occlusive vascular disease

at least one of
Occlusion of artery
Raynaud's disease
Raynaud's phenomenon

Severe hepatic impairment

Hepatic failure stage IV

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe cardiac disorders

Heart disease

Severe hypertension

Hypertension

Uterine inertia

Uterine inertia

Pre-eclampsia, eclampsia

at least one of
Pre-eclampsia
Eclampsia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: ERGOMETRINE Injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈